본문 바로가기

소아 피부근염의 임상적 특징과 예후: 후향적 연구 및 문헌 고찰

Chemical and electrochemical synthesis of cobalt hydroxides: selective phase transformation and application to distinct electrocatalytic reactions

문서 유형
연구출판물 · 학술지 논문
등재
KCIScopus
저널 순위
Scopus Q4KCI Q3
저널
대한피부과학회지59(9) · pp.699 · 2021
피인용
Scopus 0KCI 0
FWCI (Scopus)
0
ISSN
0494-4739

저자

  1. 김태림제1저자Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
  2. 배경남Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
  3. 손진화Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
  4. 신기혁Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
  5. 김훈수Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
  6. 고현창Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
  7. 김문범Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
  8. 김병수교신저자Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea

초록

Background: Juvenile dermatomyositis (JDM) is a rare but common childhood idiopathic inflammatory myopathy. Proximal muscle weakness and pathognomonic skin rash, Gottron papules, and heliotrope rash are characteristic clinical features of JDM. However, clinical analysis of JDM has rarely been reported in the Korean dermatologic literature. Objective: This study aimed to investigate the clinical features and outcomes of JDM in Korea and previous studies. Methods: We retrospectively reviewed the medical records and clinical photographs of patients diagnosed with JDM at Pusan National University Hospital (Busan and Yangsan) for 17 years (2005∼2021). Results: We encountered 12 patients with JDM (male to female ratio=7:5) with a mean age of 7.2 years. The most common clinical features were Gottron papules (100%), followed by Gottron sign (83.3%), malar rash (58.3%), heliotrope rash (41.7%), shawl sign (16.7%), calcinosis cutis (8.3%), and ulcer (8.3%). In all cases, there was no concurrent interstitial lung disease or an underlying malignancy. Only 1 of 12 patients complained of proximal muscle weakness, and four patients showed an increase in muscle enzymes in the laboratory test. The skin lesions gradually improved after systemic steroid or topical treatment in all cases. No additional proximal muscle weakness was found during the follow-up. Conclusion: Although proximal muscle weakness is a common symptom in JDM, clinically amyopathic JDM is commonly found in dermatologic clinics. Regardless of subtype, all patients responded well to treatment and rarely encountered recurrence.

키워드

DermatomyositisMuscle weakness

식별자

Scopus EID
2-s2.0-85133211818
KCI
ART002779297